FDA Import Refusal SCS-3296426-8/11/1 — CANADCARE INC.
The FDA refused shipment SCS-3296426-8/11/1 from CANADCARE INC. (Canada) on Apr 11, 2024. The refused product falls under Drugs and Biologics — INSULIN (INJ) (ANTI-DIABETIC). Cited charge: 75
Refusal details
- Date
- Apr 11, 2024
- Country
- Canada
- Product Category
- Drugs and Biologics
- Product Code
- 61PCY17 INSULIN (INJ) (ANTI-DIABETIC)
- Charges
- 75